FDA seeks more data on cancer vaccine
• ReutersPlans by US biotech company Dendreon Corp. to market a pioneering therapeutic cancer vaccine, Provenge, were dealt a blow on Wednesday when US regulators demanded more data before approving it.
Plans by US biotech company Dendreon Corp. to market a pioneering therapeutic cancer vaccine, Provenge, were dealt a blow on Wednesday when US regulators demanded more data before approving it.
